Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 370 entries
Sorted by: Best Match Show Resources per page
A brief history of antiretroviral therapy of HIV infection: success and challenges.

Annali dell'Istituto superiore di sanita

Palmisano L, Vella S.
PMID: 21430338
Ann Ist Super Sanita. 2011;47(1):44-8. doi: 10.4415/ANN_11_01_10.

Unprecedented efforts in the fields of biology, pharmacology and clinical care have contributed to progressively turn HIV infection from an inevitably fatal condition into a chronic manageable disease, at least in the countries where HIV infected people have full...

Cite
Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-8doi: 10.4415/ANN_11_01_10.
Palmisano, L., & Vella, S. (2011). A brief history of antiretroviral therapy of HIV infection: success and challenges. Annali dell'Istituto superiore di sanita, 47(1), 44-8. https://doi.org/10.4415/ANN_11_01_10
Palmisano, Lucia, and Vella, Stefano. "A brief history of antiretroviral therapy of HIV infection: success and challenges." Annali dell'Istituto superiore di sanita vol. 47,1 (2011): 44-8. doi: https://doi.org/10.4415/ANN_11_01_10
Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-8. doi: 10.4415/ANN_11_01_10. PMID: 21430338.
Copy Download .nbib Format: NLM
[What's new in HIV in 2014?].

Revue medicale suisse

Sculier D, Calmy A.
PMID: 25799673
Rev Med Suisse. 2015 Jan 14;11(456):148-52.

The latest UNAIDS GAP report suggests the end of the HIV/AIDS epidemic by 2030 based on the progress in the fight against the disease during recent years. While the number of new infections and deaths related to HIV has...

Cite
Sculier D, Calmy A. VIH: l'année 2014 en revue. [What's new in HIV in 2014?]. Rev Med Suisse. 2015;11(456):148-52
Sculier, D., & Calmy, A. (2015). VIH: l'année 2014 en revue. [What's new in HIV in 2014?]. Revue medicale suisse, 11(456), 148-52.
Sculier, Delphine, and Calmy, Alexandra. "VIH: l'année 2014 en revue." [What's new in HIV in 2014?]. Revue medicale suisse vol. 11,456 (2015): 148-52.
Sculier D, Calmy A. VIH: l'année 2014 en revue. [What's new in HIV in 2014?]. Rev Med Suisse. 2015 Jan 14;11(456):148-52. French. PMID: 25799673.
Copy Download .nbib Format: NLM
Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment.

Nursing philosophy : an international journal for healthcare professionals

Gagnon M, Holmes D.
PMID: 27435229
Nurs Philos. 2016 Oct;17(4):250-61. doi: 10.1111/nup.12136. Epub 2016 Jul 20.

Each of the antiretroviral drugs that are currently used to stop the progression of HIV infection causes its own specific side effects. Despite the expansion, multiplication, and simplification of treatment options over the past decade, side effects continue to...

Cite
Gagnon M, Holmes D. Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment. Nurs Philos. 2016;17(4):250-61doi: 10.1111/nup.12136.
Gagnon, M., & Holmes, D. (2016). Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment. Nursing philosophy : an international journal for healthcare professionals, 17(4), 250-61. https://doi.org/10.1111/nup.12136
Gagnon, Marilou, and Holmes, Dave. "Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment." Nursing philosophy : an international journal for healthcare professionals vol. 17,4 (2016): 250-61. doi: https://doi.org/10.1111/nup.12136
Gagnon M, Holmes D. Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment. Nurs Philos. 2016 Oct;17(4):250-61. doi: 10.1111/nup.12136. Epub 2016 Jul 20. PMID: 27435229; PMCID: PMC5035547.
Copy Download .nbib Format: NLM
First-line antiretroviral therapy for HIV-infected children.

AIDS (London, England)

Terris-Prestholt F.
PMID: 26035324
AIDS. 2015 Jun 19;29(10):1261-2. doi: 10.1097/QAD.0000000000000727.

No abstract available.

Cite
Terris-Prestholt F. First-line antiretroviral therapy for HIV-infected children. AIDS. 2015;29(10):1261-2doi: 10.1097/QAD.0000000000000727.
Terris-Prestholt, F. (2015). First-line antiretroviral therapy for HIV-infected children. AIDS (London, England), 29(10), 1261-2. https://doi.org/10.1097/QAD.0000000000000727
Terris-Prestholt, Fern. "First-line antiretroviral therapy for HIV-infected children." AIDS (London, England) vol. 29,10 (2015): 1261-2. doi: https://doi.org/10.1097/QAD.0000000000000727
Terris-Prestholt F. First-line antiretroviral therapy for HIV-infected children. AIDS. 2015 Jun 19;29(10):1261-2. doi: 10.1097/QAD.0000000000000727. PMID: 26035324.
Copy Download .nbib Format: NLM
Race and response to HIV treatment.

Journal watch. AIDS clinical care

Chimienti SN.
PMID: 27652434
J Watch AIDS Clin Care. 2011 May;23(5):41-2.

No abstract available.

Cite
Chimienti SN. Race and response to HIV treatment. J Watch AIDS Clin Care. 2011;23(5):41-2
Chimienti, S. N. (2011). Race and response to HIV treatment. Journal watch. AIDS clinical care, 23(5), 41-2.
Chimienti, Sonia Nagy. "Race and response to HIV treatment." Journal watch. AIDS clinical care vol. 23,5 (2011): 41-2.
Chimienti SN. Race and response to HIV treatment. J Watch AIDS Clin Care. 2011 May;23(5):41-2. PMID: 27652434.
Copy Download .nbib Format: NLM
Assessment of quality of antiretroviral therapy services in India, 2014-2015.

International health

Bhushan Rewari B, Agarwal R, Reddy Allam R, Chava N, Rathore AS.
PMID: 28911124
Int Health. 2017 Sep 01;9(5):301-309. doi: 10.1093/inthealth/ihx026.

BACKGROUND: Following a decade of provision of free antiretroviral therapy (ART) in India, a nationwide assessment of ART services was conducted to review quality of care at ART centers. This paper presents the methods and defines replicable model of...

Cite
Bhushan Rewari B, Agarwal R, Reddy Allam R, et al. Assessment of quality of antiretroviral therapy services in India, 2014-2015. Int Health. 2017;9(5):301-309doi: 10.1093/inthealth/ihx026.
Bhushan Rewari, B., Agarwal, R., Reddy Allam, R., Chava, N., & Rathore, A. S. (2017). Assessment of quality of antiretroviral therapy services in India, 2014-2015. International health, 9(5), 301-309. https://doi.org/10.1093/inthealth/ihx026
Bhushan Rewari, Bharat, et al. "Assessment of quality of antiretroviral therapy services in India, 2014-2015." International health vol. 9,5 (2017): 301-309. doi: https://doi.org/10.1093/inthealth/ihx026
Bhushan Rewari B, Agarwal R, Reddy Allam R, Chava N, Rathore AS. Assessment of quality of antiretroviral therapy services in India, 2014-2015. Int Health. 2017 Sep 01;9(5):301-309. doi: 10.1093/inthealth/ihx026. PMID: 28911124.
Copy Download .nbib Format: NLM
A Systematic Review of Health Literacy Interventions for People Living with HIV.

AIDS and behavior

Perazzo J, Reyes D, Webel A.
PMID: 26864691
AIDS Behav. 2017 Mar;21(3):812-821. doi: 10.1007/s10461-016-1329-6.

Health literacy significantly impacts health-related outcomes among people living with HIV. Our aim was to systematically review current literature on health literacy interventions for people living with HIV. The authors conducted a thorough literature search following the PRISMA statement...

Cite
Perazzo J, Reyes D, Webel A. A Systematic Review of Health Literacy Interventions for People Living with HIV. AIDS Behav. 2017;21(3):812-821doi: 10.1007/s10461-016-1329-6.
Perazzo, J., Reyes, D., & Webel, A. (2017). A Systematic Review of Health Literacy Interventions for People Living with HIV. AIDS and behavior, 21(3), 812-821. https://doi.org/10.1007/s10461-016-1329-6
Perazzo, Joseph, et al. "A Systematic Review of Health Literacy Interventions for People Living with HIV." AIDS and behavior vol. 21,3 (2017): 812-821. doi: https://doi.org/10.1007/s10461-016-1329-6
Perazzo J, Reyes D, Webel A. A Systematic Review of Health Literacy Interventions for People Living with HIV. AIDS Behav. 2017 Mar;21(3):812-821. doi: 10.1007/s10461-016-1329-6. PMID: 26864691; PMCID: PMC5484044.
Copy Download .nbib Format: NLM
Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Wilson D, Fraser N.
PMID: 24926029
Clin Infect Dis. 2014 Jul;59:S28-31. doi: 10.1093/cid/ciu300.

Treatment as prevention (TasP) has been added to the toolbox of human immunodeficiency virus (HIV) prevention technologies, and countries are at different stages of TasP deployment. In this article we review some of the cost implications and summarize effectiveness...

Cite
Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014;59:S28-31doi: 10.1093/cid/ciu300.
Wilson, D., & Fraser, N. (2014). Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 59S28-31. https://doi.org/10.1093/cid/ciu300
Wilson, David, and Fraser, Nicole. "Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 59 (2014): S28-31. doi: https://doi.org/10.1093/cid/ciu300
Wilson D, Fraser N. Who pays and why? Costs, effectiveness, and feasibility of HIV treatment as prevention. Clin Infect Dis. 2014 Jul;59:S28-31. doi: 10.1093/cid/ciu300. PMID: 24926029.
Copy Download .nbib Format: NLM
White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy.

AIDS (London, England)

Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB.
PMID: 27149087
AIDS. 2016 Sep 24;30(15):2329-39. doi: 10.1097/QAD.0000000000001133.

OBJECTIVES: The objective of this study was to assess whether HIV-infected patients on long-term successful combination antiretroviral therapy (cART) have more extensive white matter hyperintensities (WMH) of presumed vascular origin compared with uninfected controls and whether these intensities are...

Cite
Su T, Wit FW, Caan MW, et al. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS. 2016;30(15):2329-39doi: 10.1097/QAD.0000000000001133.
Su, T., Wit, F. W., Caan, M. W., Schouten, J., Prins, M., Geurtsen, G. J., Cole, J. H., Sharp, D. J., Richard, E., Reneman, L., Portegies, P., Reiss, P., Majoie, C. B. (2016). White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS (London, England), 30(15), 2329-39. https://doi.org/10.1097/QAD.0000000000001133
Su, Tanja, et al. "White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy." AIDS (London, England) vol. 30,15 (2016): 2329-39. doi: https://doi.org/10.1097/QAD.0000000000001133
Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB. White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS. 2016 Sep 24;30(15):2329-39. doi: 10.1097/QAD.0000000000001133. PMID: 27149087.
Copy Download .nbib Format: NLM
Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines.

AIDS (London, England)

Essajee S, Kumarasamy N.
PMID: 24849474
AIDS. 2014 Mar;28:S147-9. doi: 10.1097/QAD.0000000000000238.

No abstract available.

Cite
Essajee S, Kumarasamy N. Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines. AIDS. 2014;28:S147-9doi: 10.1097/QAD.0000000000000238.
Essajee, S., & Kumarasamy, N. (2014). Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines. AIDS (London, England), 28S147-9. https://doi.org/10.1097/QAD.0000000000000238
Essajee, Shaffiq, and Kumarasamy, Nagalingeswaran. "Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines." AIDS (London, England) vol. 28 (2014): S147-9. doi: https://doi.org/10.1097/QAD.0000000000000238
Essajee S, Kumarasamy N. Commentary: The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines. AIDS. 2014 Mar;28:S147-9. doi: 10.1097/QAD.0000000000000238. PMID: 24849474.
Copy Download .nbib Format: NLM
Quality in HIV/AIDS care.

Journal of general internal medicine

Frank M.
PMID: 9276663
J Gen Intern Med. 1997 Aug;12(8):517-8. doi: 10.1007/BF02719632.

No abstract available.

Cite
Frank M. Quality in HIV/AIDS care. J Gen Intern Med. 1997;12(8):517-8doi: 10.1007/BF02719632.
Frank, M. (1997). Quality in HIV/AIDS care. Journal of general internal medicine, 12(8), 517-8. https://doi.org/10.1007/BF02719632
Frank, M. "Quality in HIV/AIDS care." Journal of general internal medicine vol. 12,8 (1997): 517-8. doi: https://doi.org/10.1007/BF02719632
Frank M. Quality in HIV/AIDS care. J Gen Intern Med. 1997 Aug;12(8):517-8. doi: 10.1007/BF02719632. PMID: 9276663.
Copy Download .nbib Format: NLM
Side effects. Male sexual dysfunction and HAART--the confusion continues.

TreatmentUpdate

[No authors listed]
PMID: 12141281
TreatmentUpdate. 2002 Jul;14(5):4.

No abstract available.

Cite
Side effects. Male sexual dysfunction and HAART--the confusion continues. TreatmentUpdate. 2002;14(5):4
(2002). Side effects. Male sexual dysfunction and HAART--the confusion continues. TreatmentUpdate, 14(5), 4.
"Side effects. Male sexual dysfunction and HAART--the confusion continues." TreatmentUpdate vol. 14,5 (2002): 4.
Side effects. Male sexual dysfunction and HAART--the confusion continues. TreatmentUpdate. 2002 Jul;14(5):4. PMID: 12141281.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 370 entries